影响瘤微环境中Th17细胞的益处和致病性因素
Jie Xing1, Changfeng Man2, Yingzhao Liu3
1Department of Laboratory Medicine, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.
Frontiers in immunology
|September 8, 2023
概括
瘤微环境影响T辅助17 (Th17) 细胞,影响瘤生长. 了解这些相互作用为癌症免疫治疗提供了新的途径.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 瘤发育涉及一个复杂的微环境,具有多样化的细胞和分子组成部分.
- 帮助T细胞17 (Th17),CD4+T细胞的一个子集,在免疫和炎症中发挥着关键作用.
- Th17细胞在瘤微环境中表现出上下文依赖的功能,影响瘤的进展.
研究的目的:
- 审查Th17细胞在瘤进展中的多方面的作用.
- 研究瘤微环境如何调节Th17细胞功能.
- 探索针对Th17细胞的潜力,用于新的癌症免疫疗法策略.
主要方法:
- 关于癌症Th17细胞研究的文献综述.
- 对调节瘤Th17细胞行为的分子信号的分析.
- 评估Th17细胞对抗瘤和瘤效应的证据.
主要成果:
- 瘤微环境决定了Th17细胞的增殖,分化和功能.
- Th17细胞可以发挥双重作用,促进或抑制瘤生长.
- 瘤微环境中的特定分子线索导致不同的Th17细胞表型和活动.
结论:
- Th17细胞活动具有高度的可塑性,并受到瘤微环境的显著影响.
- 准Th17细胞介导的免疫反应对癌症免疫疗法具有前景.
- 对瘤内Th17细胞调节的进一步研究对于开发有效的治疗方法至关重要.
相关概念视频
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
01:24T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
01:27Tumor Immunotherapy
554
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
01:22T Cell Activation and Clonal Selection
801
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
801
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
01:27Cytotoxic T Cells-mediated Immune Response
959
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
959